Viewing Study NCT02482792


Ignite Creation Date: 2025-12-24 @ 3:38 PM
Ignite Modification Date: 2025-12-29 @ 10:56 PM
Study NCT ID: NCT02482792
Status: COMPLETED
Last Update Posted: 2017-10-27
First Post: 2015-06-09
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Norwegian Psychomotor Physiotherapy in Patients With Long-lasting Musculoskeletal Pain.
Sponsor: Tove Dragesund
Organization:

Study Overview

Official Title: Norwegian Psychomotor Physiotherapy Versus Cognitive Patient Education and Active Physiotherapy
Status: COMPLETED
Status Verified Date: 2017-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: NPMP
Brief Summary: The aim is to examine the effect of Norwegian Psychomotor Physiotherapy (NPMP) in employees with long-lasting musculoskeletal pain compared to employees receiving Cognitive Patient Education in combination with active individual physiotherapy (COPE-PT) on pain, function, quality of life and sick-leave
Detailed Description: The NPMP is based on the assumption that patients with long-lasting problems, physical and/or psychological, may react with general aberrations related to posture, respiration, and movements, as well as with muscular tension and skin changes.

Employees With Long lasting musculoskeletal pain problems, working in the Municipality of Bergen, will be invited to participate in an Randomized Clinical Trial (RCT), and randomized to either receive Norwegian Psychomotor Physiotherapy (NPMP) or a series of Cognitive Patient Education in combination with active individual physiotherapy (COPE-PT). The aim is to examine the effect of NPMP compared to those receiving COPE-PT on pain, function, quality of life and sick-leave.

Study Oversight

Has Oversight DMC: True
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: